Calise SJ, Abboud G, Kasahara H, Morel L, Chan EKL. Immune response-dependent assembly of IMP dehydrogenase filaments. Front Immunol. 2018;9:2789.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Yang S, Li Y, Ziwen X, Zhang P, Song Q, et al. De novo nucleotide biosynthetic pathway and cancer. Genes Dis. 2023;10:2331–8.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Pascual J, Sha P, Garcia-Garcia E, Rajeshkumar NV, De Vicente E, Quijano Y, et al. A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Invest N Drugs. 2013;31:14–9.

Article  CAS  Google Scholar 

He X, Cui J, Ma H, Abuduaini N, Huang Y, Tang L, et al. Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer. Biochem Pharmacol. 2023;218:115868.

Article  CAS  PubMed  Google Scholar 

Floryk D, Thompson TC. Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer. 2008;123:2294–302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hood KA, Zarembski DG. Mycophenolate mofetil: a unique immunosuppressive agent. Am J Health Syst Pharmacol. 1997;54:285–94.

Article  CAS  Google Scholar 

Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, et al. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol. 1998;6:251–9.

Article  CAS  PubMed  Google Scholar 

Staatz CE, Tett SE. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol. 2014;88:1351–89.

Article  CAS  PubMed  Google Scholar 

Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, et al. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017;17:1255–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prestipino A, Zeiser R. Clinical implications of tumor-intrinsic mechanisms regulating PD-L1. Sci Transl Med. 2019;11:eaav4810.

Article  CAS  PubMed  Google Scholar 

Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms controlling PD-L1 expression in cancer. Mol Cell. 2019;76:359–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang F, Huffman KE, Wang Z, Wang X, Li K, Cai F, et al. Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer. J Clin Invest. 2021;131:e139929.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen B, Hu J, Hu X, Chen H, Bao R, Zhou Y, et al. DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion. Nat Commun. 2022;13:2059.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Z, Wu C, Chen M, Jiang Y, Wu Y, Mao R, et al. The generation of PD-L1 and PD-L2 in cancer cells: from nuclear chromatin reorganization to extracellular presentation. Acta Pharm Sin B. 2022;12:1041–53.

Article  CAS  PubMed  Google Scholar 

Schoenberg DR, Maquat LE. Regulation of cytoplasmic mRNA decay. Nat Rev Genet. 2012;13:246–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vlasova-St Louis I, Bohjanen PR. Post-transcriptional regulation of cytokine and growth factor signaling in cancer. Cytokine Growth Factor Rev. 2017;33:83–93.

Article  CAS  PubMed  Google Scholar 

Yang K, Zhou J, Chen Y, Chen Y, Chen L, Zhang P, et al. Angiotensin II contributes to intratumoral immunosuppressionvia induction of PD-L1 expression in non-small cell lung carcinoma. Int Immunopharmacol. 2020;84:106507.

Article  CAS  PubMed  Google Scholar 

Zhang W, Pan X, Xu Y, Guo H, Zheng M, Chen X, et al. Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA. Acta Pharm Sin B. 2023;13:2585–600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coelho MA, de Carne Trecesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, et al. Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA. Immunity. 2017;47:1083–99. e6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91–5.

Article  CAS  PubMed  Google Scholar 

Armstrong VW, Tenderich G, Shipkova M, Parsa A, Koerfer R, Schroder H, et al. Pharmacokinetics and bioavailability of mycophenolic acid after intravenous administration and oral administration of mycophenolate mofetil to heart transplant recipients. Ther Drug Monit. 2005;27:315–21.

Article  CAS  PubMed  Google Scholar 

Xu H, Ma H, Zha L, Li Q, Yang G, Pan H, et al. IMPDH2 promotes cell proliferation and epithelial-mesenchymal transition of non-small cell lung cancer by activating the Wnt/beta-catenin signaling pathway. Oncol Lett. 2020;20:219.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sagiv-Barfi I, Kohrt HE, Czerwinski DK, Ng PP, Chang BY, Levy R. Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK. Proc Natl Acad Sci USA. 2015;112:E966–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Idos GE, Kwok J, Bonthala N, Kysh L, Gruber SB, Qu C. The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis. Sci Rep. 2020;10:3360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Youn JC, Stehlik J, Wilk AR, Cherikh W, Kim IC, Park GH, et al. Temporal trends of de novo malignancy development after heart transplantation. J Am Coll Cardiol. 2018;71:40–9.

Article  PubMed  Google Scholar 

Zeier M, Hartschuh W, Wiesel M, Lehnert T, Ritz E. Malignancy after renal transplantation. Am J Kidney Dis. 2002;39:E5.

Article  PubMed  Google Scholar 

Al-Adra D, Al-Qaoud T, Fowler K, Wong G. De novo malignancies after kidney transplantation. Clin J Am Soc Nephrol. 2022;17:434–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marcen R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69:2227–43.

Article  CAS  PubMed  Google Scholar 

Lin JY, Wang J, Mishra K, Osmani S, Rumsey K, Singh PP, et al. Non-melanoma skin cancer in solid organ transplant recipients with skin of color. J Am Acad Dermatol. 2024;90:159–60.

Article  PubMed